Equity (Tables)

3 Months Ended

Dec. 31, 2023

Equity [Abstract]

Schedule of Stock-based Compensation Expense - By Award Type

The following table sets forth stock-based compensation expense by award type:

	Three Months Ended December 31,
(in thousands)	2023		2022
RSUs	$	519	$	915
PSUs	245		693
Outside director equity awards and fees in common stock	84		126
Total stock-based compensation expense	$	848	$	1,734

Schedule of Stock-based Compensation Expense - By Expense Type

The following table sets forth stock-based compensation expense by expense type:

	Three Months Ended December 31,
(in thousands)	2023		2022
Cost of revenue	$	329	$	387
Selling, general, and administrative	375		1,075
Research and development	144		272
Total stock-based compensation expense	$	848	$	1,734

Schedule of (Loss) Income Per Share

The following table sets forth the computation of basic and diluted net loss per share:

	Three Months Ended December 31,
(in thousands, except per share data)	2023		2022
Numerator
Net loss from continuing operations	$	(4,363)	$	(8,172)
Loss from discontinued operations	$	(1,316)	$	(3,521)
Net loss	$	(5,679)	$	(11,693)
Denominator
Weighted average number of shares outstanding - basic	88,987		37,557
Effect of dilutive securities
Stock options	—		—
PSUs, RSUs, and restricted stock	—		—
Weighted average number of shares outstanding - diluted	88,987		37,557
Net loss from continuing operations per share, basic and diluted	$	(0.05)	$	(0.22)
Loss from discontinued operations per share, basic and diluted	$	(0.01)	$	(0.09)
Net loss per share, basic and diluted	$	(0.06)	$	(0.31)
Weighted average antidilutive options, unvested RSUs and RSAs, and unvested PSUs excluded from the computation	3,745		2,807

Schedule of Common Stock Reserved for Future Issuances

Common stock reserved for future issuances as of December 31, 2023 was as follows:

	Amount
Exercise of outstanding stock options	7,704
Unvested RSUs	3,758,881
Unvested PSUs (at 100% maximum payout)	1,574,668
Issuance of stock-based awards under the Equity Plans	416,612
Purchases under the officer and director share purchase plan	88,741
Total reserved	5,846,606